Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (706)	2/17/1998 11:06:00 PM
From: pappy	Respond to of 1386

Mr. Mac: I can only say one thing-You crack me up...Pappy

To: Jim Mac who wrote (706)	2/18/1998 7:11:00 PM
From: Manny Gugliuzza	Read Replies (1) \| Respond to of 1386

you can toot those other stocks all you want. but i want to see the buy and sell this year beat what lcav just did. .80cents to 2.40. your just not going to see that with those others this year. yosid had it pegged the buy to sell percentage profit ratio is with lcav... and maybe summit with a break out here in a few days. you can have the 20-30 % if you get 50-75 you should be partying. me i am going to go buy a house in puerto rico. and this is happening now so keep talking the good talk and keep watching the percentage moves. ar.

To: Jim Mac who wrote (706)	2/21/1998 2:47:00 PM
From: ajs	Read Replies (1) \| Respond to of 1386

Jim thanks for your perspective regarding the risks associated with an investment in Summit. I can assure you I am not "insecure" in my investment or in it's past performance, nor am I blindly devoted to this stock. I think we all can agree that Summit's past management (Muller) would make an excellent case study for how not to manage a company. I have committed a portion of my portfolio to this company for speculative purposes and am prepared to lose it all. I have not bailed out yet because l feel the market has punished this stock to levels where it is attractively priced relative to it's assets (cash) and potential (this story is not over). I agree several risks are looming, PPP partnership, machine inferiority (real & perceived), FDA approval, lawsuits (visx & shareholder), competition. I believe most if not all of the above will be resolved in Summit's favor, this combined with a possible acquisition, increasing procedure volume and a strong management team will cause the stock to rebound somewhat making for an attractive investment. "Investment" being the key word. As I have stated before I am long on Summit please discount my partiality.